Personalizing cancer treatment
Close to 60% of cancer patients will receive radiotherapy as part of their treatment.
Up to 10% of patients treated by radiotherapy will develop irreversible side effects.
The identification of these patients before radiotherapy initiation is essential to adapt their care pathway.
Why to use a NovaGray test?
NovaGray tests assess the patient’s individual radiosensitivity. This is an important knowledge that can contribute to:
- reassure the patient before starting radiotherapy
- guide physicians in selecting the most appropriate treatment plan
- adapt the patient’s follow-up after radiotherapy
How to perform the test?
The test is performed before starting radiotherapy.